David P Noske
Overview
Explore the profile of David P Noske including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
2207
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
12.
Hunt S, Leibner Y, Mertens E, Barros-Zulaica N, Kanari L, Heistek T, et al.
Cereb Cortex
. 2022 Jul;
33(6):2857-2878.
PMID: 35802476
Synaptic transmission constitutes the primary mode of communication between neurons. It is extensively studied in rodent but not human neocortex. We characterized synaptic transmission between pyramidal neurons in layers 2...
13.
De Swart M, Kouwenhoven M, Hellingman T, Kuiper B, Gorter de Vries C, Leembruggen-Vellinga M, et al.
Neurooncol Pract
. 2021 Sep;
8(5):559-568.
PMID: 34589232
Background: Regional collaboration and appropriate referral management are crucial in neuro-oncological care. Lack of electronic access to medical records across health care organizations impedes interhospital consultation and may lead to...
14.
Derks J, Kulik S, Numan T, de Witt Hamer P, Noske D, Klein M, et al.
Brain Connect
. 2021 May;
11(10):865-874.
PMID: 33947274
Glioma patients show increased global brain network clustering related to poorer cognition and epilepsy. However, it is unclear whether this increase is spatially widespread, localized in the (peri)tumor region only,...
15.
Teng J, Hejazi S, Hiddingh L, Carvalho L, de Gooijer M, Wakimoto H, et al.
Neuro Oncol
. 2020 Oct;
22(12):1894.
PMID: 33112953
No abstract available.
16.
Sol N, In t Veld S, Vancura A, Tjerkstra M, Leurs C, Rustenburg F, et al.
Cell Rep Med
. 2020 Oct;
1(7):100101.
PMID: 33103128
Tumor-educated platelets (TEPs) are potential biomarkers for cancer diagnostics. We employ TEP-derived RNA panels, determined by . We assessed specificity by comparing the spliced RNA profile of TEPs from glioblastoma...
17.
Dusoswa S, Verhoeff J, Abels E, Mendez-Huergo S, Croci D, Kuijper L, et al.
Proc Natl Acad Sci U S A
. 2020 Feb;
117(7):3693-3703.
PMID: 32019882
Glioblastoma is the most aggressive brain malignancy, for which immunotherapy has failed to prolong survival. Glioblastoma-associated immune infiltrates are dominated by tumor-associated macrophages and microglia (TAMs), which are key mediators...
18.
Muller D, Robe P, Eijgelaar R, Witte M, Visser M, De Munck J, et al.
JCO Clin Cancer Inform
. 2019 Jan;
3:1-12.
PMID: 30673344
Purpose: The aim of glioblastoma surgery is to maximize the extent of resection while preserving functional integrity, which depends on the location within the brain. A standard to compare these...
19.
van den Bossche W, Kleijn A, Teunissen C, Voerman J, Teodosio C, Noske D, et al.
Neuro Oncol
. 2018 May;
20(11):1494-1504.
PMID: 29796615
Background: Immunosuppressive protumoral M2 macrophages are important in pathogenesis, progression, and therapy resistance in glioblastoma (GBM) and provide a target for therapy. Recently oncolytic virotherapy in murine models was shown...
20.
Berenguer J, Lagerweij T, Zhao X, Dusoswa S, van der Stoop P, Westerman B, et al.
J Extracell Vesicles
. 2018 Apr;
7(1):1446660.
PMID: 29696074
Cancer cells release extracellular vesicles (EVs) that contain functional biomolecules such as RNA and proteins. EVs are transferred to recipient cancer cells and can promote tumour progression and therapy resistance....